In patients with chronic intrahepatic cholestasis, determination of serum AMA and PBC-specific ANA antibodies (immunofluorescence and/or specific anti-sp100/anti-gp210 testing by Western blotting or ELISA) is recommended as the next diagnostic step [51]. The gene discussed is BTG3; the disease is primary biliary cholangitis.